To assess the presence of ILF2 and ILF3 autoantibodies in human disease, we screened human sera from patients with SLE, Sjögren’s syndrome or systemic sclerosis (scleroderma) (Supplementary Fig. 4). Here, ILF3 is linked to Sjogren syndrome.